Delivery Order SPE2DB22D1017-SPE2DB24FF1VS

Award Date 1/25/24
Potential Completion Date 1/26/24
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,498.54 firm fixed-price contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a pharmaceutical product. The award has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The order has a potential value of $1,891.09 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The order has a potential value of $5,483.52 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation, is providing these brand name medications to support military treatment...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceuticals. The contract has a potential value of $10,598.71 and a completion date of January 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00 and a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialty pharmaceutical product, with a potential value of $1,412.60 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, providing a wide range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, with a potential value of $9,502.47 and a completion date of February 22, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp holds several federal contracts with...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of a pharmaceutical product - VICTOZA 3-PAK 18 MG/3 ML PEN 3ML. This contract has a potential value of $7,125.13 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not a set-aside contract. The company also holds an indefinite delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,110.14, is for the procurement of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen Drug...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $11,906.52 order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products, with a completion date of January 18, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contracts from DLA to provide pharmaceuticals, medical supplies, and related...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,237.74 firm fixed-price contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The award has a completion date of May 1, 2024 and was issued on April 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF1VS
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceuticals, with a potential value of $3,287.76. The delivery order has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, and no set-aside designation was used. This award is associated with a larger, single-award indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 4/25/24, 6:32 PM